EFFICACY OF NEBIVOLOL IN TREATMENT OF WOMEN WITH CORONARY HEART DISEASE

Aim. Evaluation of clinical efficacy and tolerability of beta-blockers in premenopausal women with stable angina.Material and methods. The anaysis of 43-55 years old premenopausal 50 women with stable angina was performed. Therapy included enalapril 2,5-10 mg daily, betaadrenoblocker in 1 group (23...

Full description

Saved in:
Bibliographic Details
Main Authors: N. A. Koryagina, A. V. Petrishcheva
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2014-12-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/162
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839576931935191040
author N. A. Koryagina
A. V. Petrishcheva
author_facet N. A. Koryagina
A. V. Petrishcheva
author_sort N. A. Koryagina
collection DOAJ
description Aim. Evaluation of clinical efficacy and tolerability of beta-blockers in premenopausal women with stable angina.Material and methods. The anaysis of 43-55 years old premenopausal 50 women with stable angina was performed. Therapy included enalapril 2,5-10 mg daily, betaadrenoblocker in 1 group (23 persons) – 5-10 mg of bisoprolol daily, and in 2 group (27 pers.) nebivolol 2,5-5 mg daily (Nebilet®, “Berlin-Chemie/A. Menarini”, Germany), acetylsalycilic acid 100 mg daily during 6 months. The studies done were veloergometry, long-lasting ECG monitoring, echocardiography and also the test with reactive hyperemia on brachial artery. Severity of anxiety-depressive syndrome was evaluated usin hospital scale of anxiety and depression, and the severity of climacteric disorders – by the M. Kuppermann index.Results. With the therapy all patients self-reported improvement of their condition: in 80% there was a decrease of angina functional class, more significant in the second group. Also there was decrease of climacteric symptoms salience as anxiety-depressive disorders, especially in nebivolol group. By the results of ECG monitoring, i. e. frequency of rhythm dosirders (supraventricular and ventricular arrhythmias) there was lower quantity of episodes, more significant in nebivolol group. All groups showed an increase of basal brachial artery diameter, more significant in the 2nd group. Also we marked the changes in central hemodynamics parameters and sctructure-functional parameters of the left ventricle in both groups. Conclusion. Nebilet® in saily dose as 2,5-5 mg is an effective antianginal drug in women with CHD and stable angina pectoris. Under Nebilet® action there is improvement of systolic and diastolic functions of the left ventricle myocardium. With Nebilet® women with stable angina significantly increase exercise tolerance and there is a decrease of climacteric and anxiety-depressive syndrome.
format Article
id doaj-art-a98af1f53c1d45bfa26d8717357cfca1
institution Matheson Library
issn 1560-4071
2618-7620
language Russian
publishDate 2014-12-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-a98af1f53c1d45bfa26d8717357cfca12025-08-04T13:00:10Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202014-12-01012717510.15829/1560-4071-2014-12-71-75162EFFICACY OF NEBIVOLOL IN TREATMENT OF WOMEN WITH CORONARY HEART DISEASEN. A. Koryagina0A. V. Petrishcheva1Perm’ State Medical Academy named after E. A. Wagner; Women Health Clinic, Perm’Perm’ State Medical Academy named after E. A. WagnerAim. Evaluation of clinical efficacy and tolerability of beta-blockers in premenopausal women with stable angina.Material and methods. The anaysis of 43-55 years old premenopausal 50 women with stable angina was performed. Therapy included enalapril 2,5-10 mg daily, betaadrenoblocker in 1 group (23 persons) – 5-10 mg of bisoprolol daily, and in 2 group (27 pers.) nebivolol 2,5-5 mg daily (Nebilet®, “Berlin-Chemie/A. Menarini”, Germany), acetylsalycilic acid 100 mg daily during 6 months. The studies done were veloergometry, long-lasting ECG monitoring, echocardiography and also the test with reactive hyperemia on brachial artery. Severity of anxiety-depressive syndrome was evaluated usin hospital scale of anxiety and depression, and the severity of climacteric disorders – by the M. Kuppermann index.Results. With the therapy all patients self-reported improvement of their condition: in 80% there was a decrease of angina functional class, more significant in the second group. Also there was decrease of climacteric symptoms salience as anxiety-depressive disorders, especially in nebivolol group. By the results of ECG monitoring, i. e. frequency of rhythm dosirders (supraventricular and ventricular arrhythmias) there was lower quantity of episodes, more significant in nebivolol group. All groups showed an increase of basal brachial artery diameter, more significant in the 2nd group. Also we marked the changes in central hemodynamics parameters and sctructure-functional parameters of the left ventricle in both groups. Conclusion. Nebilet® in saily dose as 2,5-5 mg is an effective antianginal drug in women with CHD and stable angina pectoris. Under Nebilet® action there is improvement of systolic and diastolic functions of the left ventricle myocardium. With Nebilet® women with stable angina significantly increase exercise tolerance and there is a decrease of climacteric and anxiety-depressive syndrome.https://russjcardiol.elpub.ru/jour/article/view/162ischemic heart diseasewomennebivolol
spellingShingle N. A. Koryagina
A. V. Petrishcheva
EFFICACY OF NEBIVOLOL IN TREATMENT OF WOMEN WITH CORONARY HEART DISEASE
Российский кардиологический журнал
ischemic heart disease
women
nebivolol
title EFFICACY OF NEBIVOLOL IN TREATMENT OF WOMEN WITH CORONARY HEART DISEASE
title_full EFFICACY OF NEBIVOLOL IN TREATMENT OF WOMEN WITH CORONARY HEART DISEASE
title_fullStr EFFICACY OF NEBIVOLOL IN TREATMENT OF WOMEN WITH CORONARY HEART DISEASE
title_full_unstemmed EFFICACY OF NEBIVOLOL IN TREATMENT OF WOMEN WITH CORONARY HEART DISEASE
title_short EFFICACY OF NEBIVOLOL IN TREATMENT OF WOMEN WITH CORONARY HEART DISEASE
title_sort efficacy of nebivolol in treatment of women with coronary heart disease
topic ischemic heart disease
women
nebivolol
url https://russjcardiol.elpub.ru/jour/article/view/162
work_keys_str_mv AT nakoryagina efficacyofnebivololintreatmentofwomenwithcoronaryheartdisease
AT avpetrishcheva efficacyofnebivololintreatmentofwomenwithcoronaryheartdisease